Merck Sharp & Dohme LLC v. Aurobindo Pharma Limited et al
Plaintiff: Merck Sharp & Dohme LLC
Defendant: Aurobindo Pharma Limited and Aurobindo Pharma USA, Inc.
Case Number: 1:2025cv00449
Filed: April 11, 2025
Court: U.S. District Court for the District of Delaware
Presiding Judge: Colm F Connolly
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on July 1, 2025. A more recent docket listing may be available from PACER.

Date Filed Document Text
July 1, 2025 Filing 10 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (Attachments: #1 Consent Judgment)(mws)
July 1, 2025 Filing 9 CONSENT JUDGMENT (CASE CLOSED). Signed by Judge Colm F. Connolly on 7/1/2025. (mws)
July 1, 2025 Filing 8 PROPOSED CONSENT JUDGMENT by Merck Sharp & Dohme LLC. (Joyce, Alexandra)
April 16, 2025 Filing 7 STANDING ORDER REGARDING BRIEFING IN ALL CASES (mws)
April 16, 2025 Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (alb)
April 11, 2025 Filing 6 Summons Issued as to Aurobindo Pharma Limited on 4/11/2025; Aurobindo Pharma USA, Inc. on 4/11/2025. (Attachments: #1 Summons Issued)(oam)
April 11, 2025 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merck & Co., Inc. for Merck Sharp & Dohme LLC filed by Merck Sharp & Dohme LLC. (oam)
April 11, 2025 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,326,708. (oam)
April 11, 2025 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/25/2025. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 8/25/2027. (oam)
April 11, 2025 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (oam)
April 11, 2025 Filing 1 COMPLAINT against Aurobindo Pharma Limited, Aurobindo Pharma USA, Inc. (Filing fee $ 405, receipt number ADEDC-4660319) - filed by Merck Sharp & Dohme LLC. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(oam)

Access additional case information on PACER

Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Merck Sharp & Dohme LLC v. Aurobindo Pharma Limited et al
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Merck Sharp & Dohme LLC
Represented By: Alexandra M. Joyce
Represented By: Daniel M. Silver
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Aurobindo Pharma USA, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?